Nowadays the nuclear receptors such as farnesoid X receptor (FXR) or pregnane X receptor (PXR), have been recognized as potential therapeutic targets in cholestasis (Gonzalez-Sanchez et al., 2015; Beuers et al., 2015). This evidence concerns the gene NR1I2 and cholestasis.